AstraZeneca's run of positive trial results with its cancer therapies has continued with a win for its immunotherapy Imfinzi in non-muscle invasive bladder cancer (NMIBC). Top-line results from the ...
A version of this story was originally published on Jan. 10, 2025. It has been updated to reflect the wildfires currently bringing smoke to the U.S. Interest in air filters and purifiers is spiking as ...
Want to know where interest rates may be headed? While there's no way to predict the Federal Reserve's next move, the Fed has tools that investors and consumers can look to for insights. Among them is ...
Launching a software business is far easier than starting a manufacturing venture, according to Indian entrepreneur Prakash Dadlani, who has urged the Government of India to create ready-to-use ...
Rachel Williams has been an editor for nearly two decades. She has spent the last five years working on small business content to help entrepreneurs start and grow their businesses. She’s well-versed ...
Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results